Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
73.79
-0.40 (-0.54%)
At close: Sep 16, 2025, 4:00 PM EDT
73.80
+0.01 (0.01%)
Pre-market: Sep 17, 2025, 4:49 AM EDT
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $3.71 billion as of September 17, 2025. Its market cap has increased by 85.10% in one year.
Market Cap
3.71B
Enterprise Value
3.72B
1-Year Change
85.10%
Ranking
Category
Stock Price
$73.79
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $3.71B, an increase of 1,147.21%. That is a compound annual growth rate of 50.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 3.71B | 86.75% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | 510.71M | -7.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |